pCXLE-hOCT3/4 Citations (43)
Originally described in: A more efficient method to generate integration-free human iPS cells.Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka KI, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S Nat Methods. 2011 May;8(5):409-12 PubMed Journal
Articles Citing pCXLE-hOCT3/4
| Articles |
|---|
| Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Liu GH, Suzuki K, Li M, Qu J, Montserrat N, Tarantino C, Gu Y, Yi F, Xu X, Zhang W, Ruiz S, Plongthongkum N, Zhang K, Masuda S, Nivet E, Tsunekawa Y, Soligalla RD, Goebl A, Aizawa E, Kim NY, Kim J, Dubova I, Li Y, Ren R, Benner C, del Sol A, Bueren J, Trujillo JP, Surralles J, Cappelli E, Dufour C, Esteban CR, Izpisua Belmonte JC. Nat Commun. 2014 Jul 7;5:4330. doi: 10.1038/ncomms5330. PubMed |
| Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage. Rasmussen MA, Holst B, Tumer Z, Johnsen MG, Zhou S, Stummann TC, Hyttel P, Clausen C. Stem Cell Reports. 2014 Sep 9;3(3):404-13. doi: 10.1016/j.stemcr.2014.07.006. Epub 2014 Aug 21. PubMed |
| Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT). Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B. Stem Cell Res. 2016 Jan;16(1):70-4. doi: 10.1016/j.scr.2015.12.008. Epub 2015 Dec 12. PubMed |
| Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT). Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B. Stem Cell Res. 2016 Jan;16(1):75-8. doi: 10.1016/j.scr.2015.12.006. Epub 2015 Dec 12. PubMed |
| Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia. Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B. Stem Cell Res. 2016 Jan;16(1):105-9. doi: 10.1016/j.scr.2015.12.012. Epub 2015 Dec 23. PubMed |
| Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H271. Marthaler AG, Tubsuwan A, Schmid B, Poulsen UB, Hyttel P, Nielsen JE, Nielsen TT, Holst B. Stem Cell Res. 2016 Jan;16(1):159-61. doi: 10.1016/j.scr.2015.12.027. Epub 2016 Jan 3. PubMed |
| Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H196. Marthaler AG, Schmid B, Tubsuwan A, Poulsen UB, Engelbrecht AF, Mau-Holzmann UA, Hyttel P, Nielsen JE, Nielsen TT, Holst B. Stem Cell Res. 2016 Jan;16(1):162-5. doi: 10.1016/j.scr.2015.12.031. Epub 2016 Jan 3. PubMed |
| Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H266. Marthaler AG, Schmid B, Tubsuwan A, Poulsen UB, Hyttel P, Nielsen TT, Nielsen JE, Holst B. Stem Cell Res. 2016 Jan;16(1):166-9. doi: 10.1016/j.scr.2015.12.029. Epub 2016 Jan 3. PubMed |
| Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H196. Marthaler AG, Schmid B, Tubsuwan A, Poulsen UB, Hyttel P, Nielsen TT, Nielsen JE, Holst B. Stem Cell Res. 2016 Jan;16(1):199-201. doi: 10.1016/j.scr.2015.12.049. Epub 2016 Jan 15. PubMed |
| Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1. Li T, Pires C, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Dinnyes A, Hyttel P, Freude KK. Stem Cell Res. 2016 Mar;16(2):229-32. doi: 10.1016/j.scr.2016.01.002. Epub 2016 Jan 14. PubMed |
| Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1. Li T, Pires C, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Dinnyes A, Holst B, Hyttel P, Freude KK. Stem Cell Res. 2016 Mar;16(2):334-7. doi: 10.1016/j.scr.2016.01.001. Epub 2016 Jan 14. PubMed |
| Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient. Hauser S, Erzler M, Theurer Y, Schuster S, Schule R, Schols L. Stem Cell Res. 2016 Sep 26;17(3):485-488. doi: 10.1016/j.scr.2016.09.022. PubMed |
| Generation of induced pluripotent stem cells derived from a 77-year-old healthy woman as control for age related diseases. Nimsanor N, Jorring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Bus C, Hoffmann SA, Gasser T, Kluba T, Holst B, Schmid B. Stem Cell Res. 2016 Sep 28;17(3):550-552. doi: 10.1016/j.scr.2016.09.019. PubMed |
| Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia. Nimsanor N, Jorring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Kitiyanant N, Nielsen JE, Nielsen TT, Hyttel P, Holst B, Schmid B. Stem Cell Res. 2016 Oct 20;17(3):564-567. doi: 10.1016/j.scr.2016.10.006. PubMed |
| Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5). Hoflinger P, Theurer Y, Schule R, Schols L, Hauser S. Stem Cell Res. 2016 Sep;17(2):422-425. doi: 10.1016/j.scr.2016.09.013. Epub 2016 Sep 17. PubMed |
| Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome). Hauser S, Schuster S, Theurer Y, Synofzik M, Schols L. Stem Cell Res. 2016 Sep;17(2):426-429. doi: 10.1016/j.scr.2016.09.012. Epub 2016 Sep 17. PubMed |
| Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation. Hoflinger P, Hauser S, Theurer Y, Weissenberger S, Wilke C, Schols L. Stem Cell Res. 2016 Sep;17(2):433-436. doi: 10.1016/j.scr.2016.09.010. Epub 2016 Sep 17. PubMed |
| Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5). Hauser S, Hoflinger P, Theurer Y, Rattay TW, Schols L. Stem Cell Res. 2016 Sep;17(2):437-440. doi: 10.1016/j.scr.2016.09.011. Epub 2016 Sep 18. PubMed |
| Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency. Yang Y, Liu B, Xu J, Wang J, Wu J, Shi C, Xu Y, Dong J, Wang C, Lai W, Zhu J, Xiong L, Zhu D, Li X, Yang W, Yamauchi T, Sugawara A, Li Z, Sun F, Li X, Li C, He A, Du Y, Wang T, Zhao C, Li H, Chi X, Zhang H, Liu Y, Li C, Duo S, Yin M, Shen H, Belmonte JCI, Deng H. Cell. 2017 Apr 6;169(2):243-257.e25. doi: 10.1016/j.cell.2017.02.005. PubMed |
| Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders. Hinz L, Hoekstra SD, Watanabe K, Posthuma D, Heine VM. Stem Cell Rev. 2019 Apr;15(2):276-285. doi: 10.1007/s12015-018-9851-8. PubMed |
| Generation of two iPSC lines derived from two unrelated patients with Gaucher disease. Nagel M, Reichbauer J, Bohringer J, Schelling Y, Krageloh-Mann I, Schule R, Ulmer U. Stem Cell Res. 2019 Mar;35:101336. doi: 10.1016/j.scr.2018.10.021. Epub 2018 Nov 18. PubMed |
| Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. Jaffre F, Miller CL, Schanzer A, Evans T, Roberts AE, Hahn A, Kontaridis MI. Circulation. 2019 Jul 16;140(3):207-224. doi: 10.1161/CIRCULATIONAHA.118.037227. Epub 2019 Jun 5. PubMed |
| Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network. Low JH, Li P, Chew EGY, Zhou B, Suzuki K, Zhang T, Lian MM, Liu M, Aizawa E, Rodriguez Esteban C, Yong KSM, Chen Q, Campistol JM, Fang M, Khor CC, Foo JN, Izpisua Belmonte JC, Xia Y. Cell Stem Cell. 2019 Sep 5;25(3):373-387.e9. doi: 10.1016/j.stem.2019.06.009. Epub 2019 Jul 11. PubMed |
| Lymphoblast-derived hiPS cell lines generated from four individuals of a family of genetically unrelated parents and their female monozygotic twins. Bouma MJ, Freund C, IJzerman AP, Boomsma DI, Mummery CL, Raymond K. Stem Cell Res. 2019 Dec;41:101654. doi: 10.1016/j.scr.2019.101654. Epub 2019 Nov 8. PubMed |
| Establishment of a human induced pluripotent stem cell line (CSUASOi005-A), from peripheral blood mononuclear cells of a patient with X-linked juvenile retinoschisis carrying a novel mutation in RS1 gene. Mao S, Ding C, Zhou Y, Jing Y, Chen J, Guo Y, Liu J, Cui Z, Yan X, Gu J, Wang Y, Chen J, Tang S. Stem Cell Res. 2020 Mar;43:101718. doi: 10.1016/j.scr.2020.101718. Epub 2020 Feb 4. PubMed |
| Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene. Zhou Y, Ding C, Xia S, Jing Y, Mao S, Liu J, Chen J, Chan HF, Tang S, Chen J. Stem Cell Res. 2020 Apr;44:101742. doi: 10.1016/j.scr.2020.101742. Epub 2020 Feb 21. PubMed |
| Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient. Zhou Y, Jing Y, Mao S, Liu J, Cui Z, Wang Y, Chen J, Chan HF, Tang S, Chen J. Stem Cell Res. 2020 May;45:101793. doi: 10.1016/j.scr.2020.101793. Epub 2020 Apr 20. PubMed |
| Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors. Varderidou-Minasian S, Hinz L, Hagemans D, Posthuma D, Altelaar M, Heine VM. Mol Autism. 2020 May 27;11(1):38. doi: 10.1186/s13229-020-00344-3. PubMed |
| DEPDC5 haploinsufficiency drives increased mTORC1 signaling and abnormal morphology in human iPSC-derived cortical neurons. Klofas LK, Short BP, Snow JP, Sinnaeve J, Rushing GV, Westlake G, Weinstein W, Ihrie RA, Ess KC, Carson RP. Neurobiol Dis. 2020 Sep;143:104975. doi: 10.1016/j.nbd.2020.104975. Epub 2020 Jun 20. PubMed |
| Establishment of induced pluripotent stem cell lines from a family of an ARVC patient receiving heart transplantation in infant age carrying compound heterozygous mutations in DSP gene. Xia S, Wang X, Yue P, Li Y, Zhang D. Stem Cell Res. 2020 Oct;48:101977. doi: 10.1016/j.scr.2020.101977. Epub 2020 Sep 2. PubMed |
| Mitochondria interaction networks show altered topological patterns in Parkinson's disease. Zanin M, Santos BFR, Antony PMA, Berenguer-Escuder C, Larsen SB, Hanss Z, Barbuti PA, Baumuratov AS, Grossmann D, Capelle CM, Weber J, Balling R, Ollert M, Kruger R, Diederich NJ, He FQ. NPJ Syst Biol Appl. 2020 Nov 10;6(1):38. doi: 10.1038/s41540-020-00156-4. PubMed |
| Generation of nonviral integration-free human iPS cell line KISCOi001-A from normal human fibroblasts, under defined xeno-free and feeder-free conditions. Inzunza J, Arias-Fuenzalida J, Segura-Aguilar J, Nalvarte I, Varshney M. Stem Cell Res. 2021 Mar;51:102193. doi: 10.1016/j.scr.2021.102193. Epub 2021 Jan 27. PubMed |
| Generation of two induced pluripotent stem cell lines from blood cells of a prostate cancer patient carrying germline mutation in CHEK2. Liu R, Qian K, Xiao Y, Jiang W. Stem Cell Res. 2021 May;53:102299. doi: 10.1016/j.scr.2021.102299. Epub 2021 Mar 18. PubMed |
| A de novo STUB1 variant associated with an early adult-onset multisystemic ataxia phenotype. Mengel D, Traschutz A, Reich S, Leyva-Gutierrez A, Bender F, Hauser S, Haack TB, Synofzik M. J Neurol. 2021 Apr 3. pii: 10.1007/s00415-021-10524-7. doi: 10.1007/s00415-021-10524-7. PubMed |
| Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotype. Bliley JM, Vermeer MCSC, Duffy RM, Batalov I, Kramer D, Tashman JW, Shiwarski DJ, Lee A, Teplenin AS, Volkers L, Coffin B, Hoes MF, Kalmykov A, Palchesko RN, Sun Y, Jongbloed JDH, Bomer N, de Boer RA, Suurmeijer AJH, Pijnappels DA, Bolling MC, van der Meer P, Feinberg AW. Sci Transl Med. 2021 Jul 21;13(603). pii: 13/603/eabd1817. doi: 10.1126/scitranslmed.abd1817. PubMed |
| Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues. Vermeer MC, Bolling MC, Bliley JM, Arevalo Gomez KF, Pavez-Giani MG, Kramer D, Romero-Herrera PH, Westenbrink BD, Diercks GF, van den Berg MP, Feinberg AW, Sillje HHW, van der Meer P. J Clin Invest. 2021 Jul 22. pii: e140615. doi: 10.1172/JCI140615. PubMed |
| Systematic assessment of variability in the proteome of iPSC derivatives. Beekhuis-Hoekstra SD, Watanabe K, Werme J, de Leeuw CA, Paliukhovich I, Li KW, Koopmans F, Smit AB, Posthuma D, Heine VM. Stem Cell Res. 2021 Oct;56:102512. doi: 10.1016/j.scr.2021.102512. Epub 2021 Aug 20. PubMed |
| The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease. de Rus Jacquet A, Tancredi JL, Lemire AL, DeSantis MC, Li WP, O'Shea EK. Elife. 2021 Sep 30;10. pii: 73062. doi: 10.7554/eLife.73062. PubMed |
| Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A). Mencke P, Boussaad I, Onal G, Kievit AJA, Boon AJW, Mandemakers W, Bonifati V, Kruger R. Stem Cell Res. 2022 Jul;62:102792. doi: 10.1016/j.scr.2022.102792. Epub 2022 Apr 26. PubMed |
| Establishment of fishing cat cell biobanking for sustainable conservation. Sukparangsi W, Thongphakdee A, Karoon S, Suban Na Ayuthaya N, Hengkhunthod I, Prakongkaew R, Bootsri R, Sikaeo W. Front Vet Sci. 2022 Nov 10;9:989670. doi: 10.3389/fvets.2022.989670. eCollection 2022. PubMed |
| Generation of Induced Pluripotent Stem Cells from Lymphoblastoid Cell Lines by Electroporation of Episomal Vectors. Kim M, Park J, Kim S, Han DW, Shin B, Scholer HR, Kim J, Kim KP. Int J Stem Cells. 2023 Feb 28;16(1):36-43. doi: 10.15283/ijsc22177. Epub 2022 Dec 31. PubMed |
| Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 gene encoding Miro1. Chemla A, Arena G, Onal G, Walter J, Berenguer-Escuder C, Grossmann D, Grunewald A, Schwamborn JC, Kruger R. Stem Cell Res. 2023 Jun 14;71:103145. doi: 10.1016/j.scr.2023.103145. PubMed |
| Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis. Onal G, Yalcin-Cakmakli G, Ozcelik CE, Boussaad I, Seker UOS, Fernandes HJR, Demir H, Kruger R, Elibol B, Dokmeci S, Salman MM. J Neurochem. 2024 Apr 20. doi: 10.1111/jnc.16114. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.